2011
DOI: 10.4081/reumatismo.2007.1s.25
|View full text |Cite
|
Sign up to set email alerts
|

Genetics of Psoriasis and Psoriatic Arthritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 24 publications
0
3
0
Order By: Relevance
“…We found no allelic associations that met region-wide significance criteria (α* = 8.3×10 −5 , adjusting for 601 SNPs evaluated) in the GALA II study. However, the most significant allelic association within the region in GALA II, (rs114235219, KG_ 6_31200283, p = 0.002), and the most significant SNP in the EVE asthma consortium study (rs3132550, p = 3 × 10 −4 ) were both located on PSORS1C1 , a psoriasis susceptibility candidate,(55) as were the two SNPs that achieved nominal significance in both studies (rs3094663 and rs3130564). PSORS1C1 was identified as a risk locus for systemic sclerosis,(56) Stevens-Johnson Syndrome,(57, 58), Crohn's disease,(50) COPD biomarkers,(59) and Behçet's disease(60) in GWAS.…”
Section: Discussionmentioning
confidence: 99%
“…We found no allelic associations that met region-wide significance criteria (α* = 8.3×10 −5 , adjusting for 601 SNPs evaluated) in the GALA II study. However, the most significant allelic association within the region in GALA II, (rs114235219, KG_ 6_31200283, p = 0.002), and the most significant SNP in the EVE asthma consortium study (rs3132550, p = 3 × 10 −4 ) were both located on PSORS1C1 , a psoriasis susceptibility candidate,(55) as were the two SNPs that achieved nominal significance in both studies (rs3094663 and rs3130564). PSORS1C1 was identified as a risk locus for systemic sclerosis,(56) Stevens-Johnson Syndrome,(57, 58), Crohn's disease,(50) COPD biomarkers,(59) and Behçet's disease(60) in GWAS.…”
Section: Discussionmentioning
confidence: 99%
“…Both conditions may have genetic factors, pathophysiologic overlaps, and risk factors in common. Gene polymorphisms for IL-1, IL-6, and tumor necrosis factor-a are mentioned as risk factors for both psoriasis and periodontitis (Białecka et al, 2015;Ding et al, 2014;Hébert et al, 2014;Mathieu et al 2007;McDevitt et al, 2000;Puri et al, 2015;Reich et al, 2002;Shao et al, 2009). Pathophysiologic similarity between psoriasis and periodontitis includes an activated innate immune cell compartment with neutrophil dominance and a cytokine milieu with the presence of IL-17/tumor necrosis factor-a (Boehncke, 2015;Girolomoni et al, 2012;Hajishengallis, 2014Hajishengallis, , 2015Schö n et al, 2017;Zenobia and Hajishengallis, 2015).…”
Section: Discussionmentioning
confidence: 99%
“…Similar to the condition in the majority of rheumatologic diseases, the etiology of PsA is not known exactly; nevertheless, genetic, immunologic, and environmental factors are all presumed to play roles [10]. It was demonstrated that proinflammatory cytokines, like tumor necrosis factor alpha (TNF-α) and interleukin-1 (IL-1), were increased on the skin and synovial membrane in psoriasis and PsA patients [11].…”
Section: Introductionmentioning
confidence: 99%